Skip to main content

Posts

Showing posts from October, 2018

FDA and Xarelto claims

Rivaroxaban is an oral anticoagulant drug sold under the trade name Xarelto. Manufactured by Bayer and the Johnson & Johnson subsidiary Janssen, Xarelto is prescribed for the treatment of atrial fibrillation (AFib), pulmonary embolisms (PE), deep vein thrombosis (DVT), and surgeries such as knee and hip replacements. Unfortunately, the drug has been responsible for severe side effects and even fatalities since its approval by FDA in 2011. What is Xarelto and what does it do? The drug is a prescription medication used for the treatment of deep vein thrombosis, atrial fibrillation and pulmonary embolism. What made it worse than the existing anticoagulants, even though they were called more effective by the manufacturing company is its side effects that lead to gastrointestinal, cranial, and retinal hemorrhaging. Additionally, there is no known way to call off the anticoagulant effect in case of emergency. This is a potentially fatal condition as the patient no matter how